Bone Biologics Corp. (BBLG) Monday announced a planned reverse stock split of its shares of common stock at a ratio of 1-for-8, effective 12.01 am ET December 20.
The shares of Bone Biologics are expected to trade on a post-split basis on Nasdaq under the existing trading symbol, 'BBLG,' at the market open on Wednesday.
When the reverse stock split becomes effective, every eight shares of its issued and outstanding common stock will be combined into one share of common stock.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.